Miromatrix Medical Inc.
NASDAQ:MIRO
3.39 (USD) • At close December 12, 2023
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 Q3 | 2022 Q2 | 2022 Q1 | 2021 Q4 | 2021 Q3 | 2021 Q2 | 2021 Q1 | 2020 Q4 | 2020 Q3 | 2020 Q2 | 2020 Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 0.011 | 0.009 | 0.008 | 0.93 | 0.012 | 0.004 | 0.007 | 0.008 | 0.01 | 0.009 | 0.006 | 0.015 | 0.011 | 0.009 | 0.011 |
| Cost of Revenue
| 0.125 | 0.125 | 0.125 | 0.125 | 0.125 | 0.125 | 0.125 | 0.125 | 0.125 | 0.125 | 0.125 | 0.125 | 0.125 | 0.125 | 0.125 |
| Gross Profit
| -0.114 | -0.116 | -0.117 | 0.805 | -0.113 | -0.121 | -0.118 | -0.117 | -0.115 | -0.116 | -0.119 | -0.11 | -0.114 | -0.116 | -0.114 |
| Gross Profit Ratio
| -10.185 | -13.677 | -14.662 | 0.866 | -9.085 | -30.63 | -17.469 | -14.625 | -11.73 | -12.678 | -19.465 | -7.223 | -10.525 | -12.306 | -10.273 |
| Reseach & Development Expenses
| 3.506 | 3.621 | 4.392 | 4.734 | 4.575 | 4.988 | 4.006 | 3.052 | 3.35 | 2.481 | 1.868 | 1.53 | 1.87 | 2.079 | 1.801 |
| General & Administrative Expenses
| 2.143 | 2.038 | 2.6 | 2.206 | 2.053 | 2.188 | 2.273 | 1.807 | 1.488 | 0.786 | 0.563 | 0.578 | 0.46 | 0.605 | 0.466 |
| Selling & Marketing Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| SG&A
| 2.143 | 2.038 | 2.6 | 2.206 | 2.053 | 2.188 | 2.273 | 1.807 | 1.488 | 0.786 | 0.563 | 0.578 | 0.46 | 0.605 | 0.466 |
| Other Expenses
| 3.015 | 2.951 | 0.99 | 0.927 | 1.016 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating Expenses
| 6.521 | 6.572 | 7.982 | 7.867 | 7.644 | 8.113 | 7.075 | 5.342 | 4.978 | 3.329 | 2.45 | 2.042 | 2.142 | 2.469 | 2.16 |
| Operating Income
| -6.635 | -6.688 | -8.099 | -7.061 | -7.756 | -8.234 | -7.193 | -5.459 | -5.209 | -3.573 | -2.719 | -2.35 | -2.584 | -2.871 | -2.454 |
| Operating Income Ratio
| -593.691 | -785.301 | -1,014.789 | -7.59 | -625.759 | -2,083.62 | -1,062.776 | -682.384 | -530.463 | -390.916 | -445.196 | -154.553 | -238.266 | -305.593 | -221.326 |
| Total Other Income Expenses Net
| 0.181 | 0.158 | 0.619 | 0.234 | 0.128 | 0.052 | -0.01 | -0.011 | 0.151 | -0.13 | 2.285 | 1.261 | -0.408 | -0.402 | -0.502 |
| Income Before Tax
| -6.454 | -6.53 | -7.48 | -6.946 | -7.628 | -8.182 | -7.204 | -5.476 | -5.058 | -3.703 | -0.434 | -1.088 | -2.992 | -3.273 | -2.956 |
| Income Before Tax Ratio
| -577.46 | -766.751 | -937.245 | -7.466 | -615.414 | -2,070.392 | -1,064.384 | -684.5 | -515.081 | -405.168 | -71.11 | -71.572 | -275.883 | -348.422 | -266.616 |
| Income Tax Expense
| 0.197 | 0.166 | -0.29 | 0 | -0.128 | 0.061 | 0.011 | -0.062 | 0.015 | 0.311 | 0.114 | -0.357 | -0.253 | -0.391 | -0.592 |
| Net Income
| -6.454 | -6.53 | -7.19 | -6.946 | -7.5 | -8.182 | -7.204 | -5.476 | -5.058 | -3.703 | -0.434 | -1.088 | -2.992 | -3.273 | -2.956 |
| Net Income Ratio
| -577.46 | -766.751 | -900.918 | -7.466 | -605.068 | -2,070.392 | -1,064.384 | -684.5 | -515.081 | -405.168 | -71.11 | -71.572 | -275.883 | -348.422 | -266.616 |
| EPS
| -0.24 | -0.24 | -0.32 | -0.33 | -0.36 | -0.4 | -0.35 | -0.27 | -0.25 | -1.27 | -0.024 | -0.1 | -0.28 | -0.31 | -0.28 |
| EPS Diluted
| -0.24 | -0.24 | -0.32 | -0.33 | -0.36 | -0.4 | -0.35 | -0.27 | -0.25 | -1.27 | -0.024 | -0.1 | -0.28 | -0.31 | -0.28 |
| EBITDA
| -6.15 | -6.233 | -7.47 | -6.933 | -7.331 | -7.9 | -6.929 | -5.458 | -5.058 | -3.416 | -2.762 | -2.804 | -2.716 | -3.086 | -2.84 |
| EBITDA Ratio
| -550.314 | -731.808 | -935.962 | -7.452 | -591.484 | -1,998.932 | -1,023.818 | -682.244 | -515.162 | -373.779 | -452.241 | -184.42 | -250.398 | -328.515 | -256.156 |